ImmuCell
US-based ImmuCell Corp. develops milk-derived antibody products to treat gastrointestinal infections and manufactures bovine lactoferrin.
Founded
1987US-based ImmuCell Corp. develops milk-derived antibody products to treat gastrointestinal infections and manufactures bovine lactoferrin.
Founded in Portland, United States, ImmuCell Corporation is a biotechnology company dedicated to developing and manufacturing milk-derived passive antibody products aimed at preventing and treating gastrointestinal infections in both humans and animals. Their core mission is to improve animal health and productivity through innovative solutions. Key products include First Defense®, which provides immediate protection against scours in newborn calves, and bovine lactoferrin. The company also engages in joint ventures for products like Crypto-Scan, a drinking-water test marketed in the UK.
Notable figures affiliated with ImmuCell include Brad Scott from Scott Brothers Dairy, who endorses their flagship product, First Defense®. The company has achieved significant milestones, such as securing distribution agreements and expanding their product line to include essential health solutions like bovine lactoferrin. ImmuCell's impact is evident in its contribution to improving livestock health and productivity, thereby supporting the agricultural sector with effective and reliable biotechnological advancements.
Companies similar to ImmuCell include Immunaeon, Excelimmune, IGM Biosciences and Imunon.
ImmuCell was founded in 1987.
ImmuCell's headquarters is located in Portland, ME, US.
ImmuCell's most recent funding round was for $3M (USD) in June 2023.
As of Jun 15, 2023, ImmuCell has disclosed funding of $17.7M (USD). Undisclosed round amounts are excluded.
ImmuCell has 72 employees as of Feb 6, 2024.
Imunon
imunon.com
